EMERYVILLE, Calif., May 23, 2022
/PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic
biotechnology company accelerating the world's transition to
sustainable consumption through its Lab-to-MarketTM
technology platform, today announced that management will
participate in fireside chats at the following upcoming investor
conferences.
- Morgan Stanley Sustainable Futures Conference, May 23 at 2:00 PM
ET (virtual)
- UBS Global Healthcare Conference, May
25 at 11:30 AM ET
(in-person)
Live webcasts of the presentations and replays will be available
on the Investor Relations section of the company's website at
https://investors.amyris.com/events-and-presentations.
About Amyris
Amyris (Nasdaq: AMRS) is a leading
synthetic biotechnology company, transitioning the Clean Health
& Beauty and Flavors & Fragrances markets to sustainable
ingredients through fermentation and the company's proprietary
Lab-to-MarketTM technology platform. This Amyris
platform leverages state-of-the-art machine learning, robotics and
artificial intelligence, enabling the company to rapidly bring new
innovation to market at commercial scale. Amyris ingredients are
included in over 20,000 products from the world's top brands,
reaching more than 300 million consumers. Amyris also owns and
operates a family of consumer brands that is constantly evolving to
meet the growing demand for sustainable, effective and accessible
products. For more information, please visit
http://www.amyris.com.
Amyris, the Amyris logo, Biossance, JVN, Lab-to-Market, OLIKA,
Pipette, Purecane, and Rose Inc. are trademarks or registered
trademarks of Amyris, Inc. or its subsidiaries in the U.S. and/or
other countries.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/amyris-to-participate-at-may-investor-conferences-301552644.html
SOURCE Amyris, Inc.